AI vs PAYO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and negative profitability metrics raise concerns. Despite strong gross margins and a solid balance sheet with low debt, the company is deeply unprofitable with negative earnings, shrinking revenue, and deteriorating ROE and ROA. Insider selling is aggressive, with $37.91M in sales over the last six months and no buys, while analysts show limited conviction with only a $14.67 target price. The stock trades at elevated valuation multiples despite negative earnings and declining growth, and its 5-year return of -91.4% underscores persistent underperformance.
PAYO presents a conflict between deterministic value and analyst sentiment, with a Piotroski F-Score of 4/9 indicating stable but mediocre financial health. The stock trades at a significant premium to its Graham Number ($2.94) and Intrinsic Value ($2.75), suggesting the market is pricing in future growth not yet fully realized in the trailing data. While the balance sheet is exceptionally clean with very low debt, the slow YoY revenue growth (4.9%) contrasts with a strong 'Strong Buy' analyst consensus and a target price of $7.50. Recent short-term price momentum is positive, but long-term performance remains deeply bearish.
Compare Another Pair
Related Comparisons
AI vs PAYO: Head-to-Head Comparison
This page compares C3.ai, Inc. (AI) and Payoneer Global Inc. (PAYO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.